5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Endothelial activation, innate immune activation, and inflammation are associated with post-bronchodilator airflow limitation and obstruction among adolescents living with HIV

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background:

          Chronic inflammation, innate immune activation, T-cell imbalance and endothelial activation have been linked with lung diseases. We sought to determine whether markers of these pathophysiologic pathways were associated with spirometry and chest CT abnormalities among adolescents living with HIV (ALWH).

          Setting:

          Coptic Hope Center for Infectious Diseases in Nairobi, Kenya

          Methods:

          We performed a cross-sectional study of ALWH (10–19 years old). Participants underwent chest CT, spirometry and venipuncture for serum biomarkers. We also collected demographic, anthropometric, T-cell subset, antiretroviral therapy, and exposure data. We compared characteristics and biomarkers by airflow obstruction (post-bronchodilator FEV 1/FVC z-score [zFEV 1/FVC] < −1.64). We used multivariable linear regression to determine associations of log 10-transformed biomarkers and chest CT abnormalities with lower post-bronchodilator zFEV 1/FVC (airflow limitation). We performed exploratory principal components analysis on biomarkers, and determined associations of factors with post-bronchodilator zFEV 1/FVC and chest CT abnormalities.

          Results:

          Of 47 participants with acceptable quality spirometry, 21 (45%) were female, median age was 13 years and 96% had perinatally-acquired HIV. Median CD4 was 672 cells/μL. Overall, 28% had airflow obstruction and 78% had a chest CT abnormality; airflow obstruction was associated with mosaic attenuation ( p=0.001). Higher endothelial activation (sVCAM-1, sICAM-1), inflammation and innate immune activation (SAA, sTREM-1, sCD163), and T-cell imbalance (lower CD4/CD8) markers were associated with airflow limitation. Factors comprising endothelial and innate immune activation were associated with airflow limitation.

          Conclusions:

          Endothelial activation, innate immune activation, T-cell imbalance, and chronic inflammation are associated with airflow limitation and obstruction, providing insights into chronic lung disease pathophysiology among ALWH.

          Related collections

          Author and article information

          Journal
          100892005
          21821
          J Acquir Immune Defic Syndr
          J Acquir Immune Defic Syndr
          Journal of acquired immune deficiency syndromes (1999)
          1525-4135
          1944-7884
          13 January 2020
          01 March 2020
          01 March 2021
          : 83
          : 3
          : 267-277
          Affiliations
          [1 ]University of Washington, Division of Pulmonary, Critical Care and Sleep Medicine, Seattle, WA,
          [2 ]University of Washington, International Respiratory and Severe Illness Center, Seattle, WA,
          [3 ]Fred Hutchinson Cancer Research Center, Clinical Research Center, Seattle, WA,
          [4 ]University of Washington, Department of Medicine, Seattle, WA,
          [5 ]University of Nairobi, Department of Paediatric and Child Health, Nairobi, Kenya,
          [6 ]University of Washington, Department of Global Health, Seattle, WA,
          [7 ]Coptic Hospital, Nairobi, Kenya,
          [8 ]Coptic Hope Center for Infectious Diseases, Nairobi, Kenya,
          [9 ]University of Washington, Department of Radiology and Cardiothoracic Imaging, Seattle, WA,
          [10 ]University of Washington, Department of Epidemiology, Seattle, WA,
          [11 ]VA Puget Sound Health Care System, Division of Pulmonary, Critical Care and Sleep Medicine, Seattle, WA,
          [12 ]University of Washington, Department of Pathology, Seattle, WA,
          [13 ]University of Washington, Department of Pharmacology, Seattle, WA,
          Author notes
          Corresponding Author: Engi F. Attia, MD MPH, 325 Ninth Avenue, Campus Box 359762, Harborview Medical Center, Seattle, WA 98144, Phone: +1 206 744 3244, Fax: +1 206 744 8584, eattia@ 123456uw.edu
          Article
          PMC7735385 PMC7735385 7735385 nihpa1549553
          10.1097/QAI.0000000000002255
          7735385
          32032277
          d542cca1-886b-44a2-a82f-81b47f87515e
          History
          Categories
          Article

          innate immune activation,endothelial activation,airflow limitation/obstruction,adolescents,HIV,T-cell imbalance

          Comments

          Comment on this article